Inspirata Inc, Tampa, Fla, has acquired Omnyx, Pittsburgh, Pa, from GE Healthcare.
Omnyx’ flagship digital pathology software product, Dynamyx, was developed to enhance the pathology workflow by providing new channels for collaboration and tools to boost efficiency. The software has the CE mark, and is licensed by Health Canada for in vitro diagnostic (IVD) use.
“The acquisition of Omnyx positions Inspirata with the most comprehensive digital pathology workflow solution in the world,” says Satish Sanan, chief executive of Inspirata. “It brings us the last mile to reach our goal of having an end-to-end integrated pathology solution with a scanner-agnostic whole-slide image viewer and image management system. It also gives us a fully supported IVD device cleared for primary digital diagnosis in Europe and Canada, and it expands our customer base and geographic footprint across those countries.”
Inspirata plans to retain Omnyx’ office and employees. The company will use the location and related resources to create a center of excellence for ongoing digital pathology software development. “Our short-term plan is to rapidly combine the advantages of our digital pathology software platform and the Dynamyx platform by converging them onto a shared, state-of-the-art technology stack,” says Sanan.
“Inspirata has shown a strong commitment to promoting the adoption of digital pathology to improve cancer diagnostics,” says Andrew Chomos, chief executive of Omnyx. “By combining our platforms, we will be able to offer a device and application-agnostic solution in both Europe and Canada that can integrate with pathology departments’ existing hardware and health information systems.”
For more information, visit Inspirata.
